• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Forbes Norris Award

The Forbes Norris Award was established in 1994 to honour the legacy of Dr. Forbes “Ted” Norris (1928–1993), a neurologist who dedicated his life to supporting people living with ALS/MND. This prestigious award recognizes individuals whose work advances clinical care, research, and understanding of ALS/MND for the benefit of those living with the disease.

To be considered for the Forbes Norris Award, candidates must:

  • Play a major role in delivering outstanding ALS/MND patient care
  • Contribute significantly to medical literature in clinical management or basic science related to ALS/MND
  • Be part of a team engaged in ongoing research into ALS/MND care, management, or basic science

The award is presented annually during the opening ceremony of the MND Association’s International Symposium on ALS/MND. If no suitable candidate is nominated in a given year, the award will not be granted. Please note that current Board of Directors are not eligible for nomination.

The 2026 nomination period is open. The deadline to submit your nominations is Tuesday, September 15.

Forbes Norris Award Nomination Form

  • (No self-nominations please)
  • Accepted file types: doc, docx, pdf, Max. file size: 128 MB.
    Please use .doc, .docx, or .pdf
  • This field is for validation purposes and should be left unchanged.

Primary Sidebar

  • Chun Ju Xiao, China

    Chun Ju Xiao, China

  • Cliff Marshman, USA

    Cliff Marshman, USA
    CliffMarshman

  • Danny Reviers, Belgium

    Danny Reviers, Belgium

  • Sally Pauls, USA

    Sally Pauls, USA

  • Glen Victor Peters, Australia

    Glen Victor Peters, Australia

  • Stephanie Christiansen Hall, Canada

    Stephanie Christiansen Hall, Canada

  • Guido De Mets, Belgium

    Guido De Mets, Belgium

  • David Bishop, UK

    David Bishop, UK

  • Sharon Corosanite, USA

    Sharon Corosanite, USA

  • Danny Reviers, Belgium

    Danny Reviers, Belgium
    DannyReviers

  • Natalya Rybakova, Russia

    Natalya Rybakova, Russia

  • Eddy Lefrancois, Canada

    Eddy Lefrancois, Canada

  • Camilla Heiberg Freiberg, Denmark

    Camilla Heiberg Freiberg, Denmark

  • Fabrice Kamp, Germany

    Fabrice Kamp, Germany

  • Ana María Zavala, Mexico

    Ana María Zavala, Mexico

  • Bruno Leanza Mantegna, Italy

    Bruno Leanza Mantegna, Italy

  • Duncan Bayly, Australia

    Duncan Bayly, Australia

  • Alfredo Santos, Colombia

    Alfredo Santos, Colombia

  • Jose Espinosa, Argentina

    Jose Espinosa, Argentina

  • Irene McCaughey, Australia

    Irene McCaughey, Australia

  • Juvenal Bayona Romero, Colombia

    Juvenal Bayona Romero, Colombia

  • Dick Dayton, USA

    Dick Dayton, USA

  • Rudiger Hanemann, Germany

    Rudiger Hanemann, Germany

  • Hanne Stenmose, Denmark

    Hanne Stenmose, Denmark

  • Andrea Zicchieri, Italy

    Andrea Zicchieri, Italy
    AndreaZicchieri_conSLAncioItaly

  • Rolf Mauch, Switzerland

    Rolf Mauch, Switzerland

  • Liong Ting Ngu, Malaysia

    Liong Ting Ngu, Malaysia

  • Gisli Jonasson, Iceland

    Gisli Jonasson, Iceland

  • Len Johnrose, England

    Len Johnrose, England

  • Armando González Gómez, Colombia

    Armando González Gómez, Colombia

  • Fabio Correia, Brazil

    Fabio Correia, Brazil

  • Peng Yi-Wen, Taiwan

    Peng Yi-Wen, Taiwan

  • Dawn Morton, Scotland

    Dawn Morton, Scotland

  • Chirag Walia, India

    Chirag Walia, India
    ChiragWalia

  • Ailsa Malcolm-Hutton, UK

    Ailsa Malcolm-Hutton, UK

  • Chen Yin Xue, Taiwan

    Chen Yin Xue, Taiwan

  • Brian Lovell, Australia

    Brian Lovell, Australia

  • Maria Lucia Wood Saldanha, Brazil

    Maria Lucia Wood Saldanha, Brazil

  • Lucy Lintott, Scotland

    Lucy Lintott, Scotland

  • Ismail Gokcek, Turkey

    Ismail Gokcek, Turkey
    ismail_gokcek_alsmnd_tr

  • Art Eggert, USA

    Art Eggert, USA

  • Imelda Arenas, Colombia

    Imelda Arenas, Colombia

  • Xian-Zhang Niu, China

    Xian-Zhang Niu, China

  • Mauricio Dorin, Argentina

    Mauricio Dorin, Argentina

  • Yolanda Armendariz, Mexico

    Yolanda Armendariz, Mexico

  • Monica Soriano, Argentina

    Monica Soriano, Argentina

  • Ada Garrido Benavidez, Mexico

    Ada Garrido Benavidez, Mexico

  • Anita Forte, USA

    Anita Forte, USA

  • Kirsty Gerlach, New Zealand

    Kirsty Gerlach, New Zealand

  • Greg Heydet, USA

    Greg Heydet, USA

Learn more about the March of Faces

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login